Pregnancy and neonatal safety outcomes of timing of initiation of daily oral tenofovir disoproxil fumarate and emtricitabine pre-exposure prophylaxis for HIV prevention (CAP016): an open-label, randomised, non-inferiority trial
Dhayendre Moodley, Carl Lombard, Vani Govender, Megeshinee Naidoo, Alicia C. Desmond, Kimesh Naidoo, Ottacia Mhlongo, Motshedisi Sebitloane, Marie‐Louise Newell, Richard Clark, James F. Rooney, Glenda Gray, Dhayendre Moodley, Carl Lombard, Vani Govender, Megeshinee Naidoo, Alicia C. Desmond, Kimesh Naidoo, Ottacia Mhlongo, Motshedisi Sebitloane, Marie‐Louise Newell, Richard Clark, James F. Rooney, Glenda Gray, Linda Ngaleka, Natasha Pillay, Samkelo Booi, Natasha Samsunder, Lorna Pillay, Rosemary Gray, Rosemary Gazu, Thandeka Nkosi, Rosemary Gazu, Thandeka Nkosi
Topics & Concepts
MedicineEmtricitabinePre-exposure prophylaxisPregnancyObstetricsGestational ageBreastfeedingSmall for gestational ageRandomized controlled trialPediatricsHuman immunodeficiency virus (HIV)Internal medicineViral loadAntiretroviral therapyMen who have sex with menSyphilisFamily medicineGeneticsBiologyHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV-related health complications and treatments